Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37%. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.
No link between breast cancer and meningioma : results from a large monoinstitutional retrospective analysis / C. Criscitiello, D. Disalvatore, M. Santangelo, N. Rotmensz, B. Bazolli, P. Maisonneuve, A. Goldhirsch, G. Curigliano. - In: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. - ISSN 1055-9965. - 23:1(2014), pp. 215-217. [10.1158/1055-9965.EPI-13-1041]
No link between breast cancer and meningioma : results from a large monoinstitutional retrospective analysis
C. Criscitiello;G. Curigliano
2014
Abstract
Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37%. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.File | Dimensione | Formato | |
---|---|---|---|
215.full.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
232.35 kB
Formato
Adobe PDF
|
232.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.